Role of neoadjuvant treatment in resectable pancreatic cancer according to vessel invasion and increase of CA19 ‐9 levels

ConclusionsNAT showed better survival than upfront surgery in resectable pancreatic cancer. In patients with PV/SMV contact or CA19-9>150 U/mL, NAT showed a survival difference compared to upfront surgery; therefore, NAT could be considered in these patients.

Source: Journal of Hepato-Biliary-Pancreatic Surgery - January 18, 2023 Category: Surgery Authors: Hyeong Seok Kim, Mirang Lee, Youngmin Han, Jae Seung Kang, Yoon Hyung Kang, Hee Ju Sohn, Wooil Kwon, Dong Ho Lee, Jin ‐Young Jang Tags: ORIGINAL ARTICLE Source Type: research